Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ribotech

Ribotech
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of pharmaceutical products. The company develops and offers drugs used in the treatment of cancer patients suffering from neutropenia, a low white blood cell count as a result of chemotherapy treatment.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 15a Mail Street
  • Epping Industrial
  • Goodwood, 7460
  • South Africa

+27 021 000 0000

Ribotech Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ribotech‘s full profile, request access.

Request full access to PitchBook

Ribotech Executive Team (1)

Name Title Board
Seat
Contact
Info
Fran Mochaba Ph.D Chief Production Manager & Member Board of Directors

Ribotech Board Members (2)

Name Representing Role Since Contact
Info
0000 0000000 00.0 Ribotech Chief Production Manager & Member Board of Directors 000 0000
0000 0000000-0000 Ribotech Independent Non Executive Director 000 0000